QR Code

Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer

PURPOSE: High interest in triple-negative breast cancers is not surprising as this category of patients benefits neither from hormonal therapies nor from anti HER2 treatments. Blockade of angiogenesis by metronomic chemotherapy as well as other antiangiogenics might improve outcomes in this group of...

Full description

Saved in:
Main Authors: HA Alagizy, MA Shehata, TA Hashem, KK Abdelaziz, MM Swiha
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Hematology/Oncology and Stem Cell Therapy
Subjects:
triple-negative breast cancer
metronomic chemotherapy
capecitabine
extended adjuvant treatment
Online Access:https://journals.lww.com/10.1016/j.hemonc.2014.11.003
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items